Medscape Medical NewsAll articles

Deep Learning Image Reconstruction

GE Healthcare Japan Corporation • Radiology • 07/29/2022

510(k)IEC 62304 Class B
FDA Summary PDF

Device Purpose

The Deep Learning Image Reconstruction software employs a dedicated Deep Neural Network for generating CT images across various anatomical regions and patient populations, aiming to replicate traditional image appearance while enhancing quality metrics like noise reduction and spatial resolution. This iteration ports the established algorithm to the Discovery CT750 HD family of CT systems, leveraging GE's Edison Platform for deployment.

Summary

GE Healthcare's Deep Learning Image Reconstruction (DLIR) is a software designed to produce cross-sectional computed tomography (CT) images of the head and whole body. It utilizes a dedicated Deep Neural Network (DNN) to reconstruct images from X-ray transmission data acquired through Axial, Helical (Volumetric), and Cardiac scans, suitable for all patient ages. The software is intended for head, whole body, cardiac, and vascular CT applications, producing images branded as "TrueFidelityTM CT Images" and offering user-selectable strengths of Low, Medium, or High for image reconstruction. The DLIR software's DNN is specifically trained to generate CT images with an appearance comparable to traditional Filtered Back Projection (FBP) methods, while aiming to achieve performance levels equal to or better than GE's ASiR-V technology in terms of radiation dose efficiency, image noise (pixel standard deviation), low contrast detectability, high-contrast spatial resolution, and streak artifact suppression. This submission details the porting of the existing DLIR algorithm to the Discovery CT750 HD family of CT systems (including Discovery CT750 HD, Revolution Frontier, and Revolution Discovery CT). While integrated into the scanner's raw data processing chain, the deployment environment for this version is GE's Edison Platform, a change from the predicate's on-console deployment. Extensive software and IQ bench testing confirmed that the DLIR software meets its design requirements and performance criteria on these systems, maintaining image quality and diagnostic performance.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

Deep Learning Image ReconstructionComputed Tomography (CT)Deep Neural Network (DNN)Image ReconstructionTrueFidelity CT ImagesASiR-VImage Noise ReductionLow Contrast DetectabilitySpatial ResolutionDiscovery CT750 HD

Device Metadata

Submission Number
K220961
Company
GE Healthcare Japan Corporation
Panel
Radiology
Product Code
N/A
Data Type
Images
Clinical Function
Assessment
AI Function
Generation
AI Subclass
image enhancement

Relevant Clinical Questions

  • Q1. How does the performance of TrueFidelity CT Images generated by this DLIR software on the Discovery CT750 HD family compare quantitatively to traditional FBP and ASiR-V across different anatomical regions, patient demographics, and varying radiation dose levels?; What are the specific architectural characteristics of the Deep Neural Network employed, and how was its training dataset curated and validated to ensure robust performance and generalizability across diverse clinical cases and acquisition protocols on the Discovery CT750 HD systems?; Are there any known limitations or specific clinical scenarios where the different strengths (Low, Medium, High) of the DLIR software might introduce subtle image artifacts or misrepresent anatomical details compared to ASiR-V or FBP, particularly in challenging cases like pediatric or bariatric imaging?; How does the selection of DLIR strength (Low, Medium, High) quantitatively impact image noise, low contrast detectability, spatial resolution, and Hounsfield Unit accuracy, and what is the corresponding potential for radiation dose reduction while maintaining diagnostic image quality?; What is the computational demand and typical image reconstruction time for DLIR on the Discovery CT750 HD systems when deployed via GE's Edison Platform, and how does this compare to the predicate device's on-console deployment and other reconstruction methods like ASiR-V, considering clinical workflow efficiency?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score15/100
SBOM Evidence⚠ Not mentioned in summary
Cyber Risk Assessment⚠ Not mentioned in summary
Postmarket Plan⚠ Not mentioned in summary
§524B ApplicableNo

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(training data, deep learning, neural network, algorithm, dataset)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials(network, platform)
✓ Detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials(deployment, environment)
✓ Detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM, SaaSBOM, OBOM detected in AI-generated device summary.

• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, HBOM, CBOM, VDR/VEX. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
Deep Learning Image Reconstruction - GE Healthcare Japan Corporation | ESL FDA AI Device Intelligence